Fabio Pires de Souza Santos

  • Endereço para acessar este CV: http://lattes.cnpq.br/3669866735014297
  • Última atualização do currículo em 29/08/2014


Possui graduação em Medicina pela Universidade de São Paulo (2002). Realizou residência de Hematologia no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo de 2005-2007. Foi médico visitante do Departamento de Leucemias do M.D. Anderson Cancer Center da Universidade do Texas em 2004 e 2007. Realizou fellowship de especialização clínica em Leucemias, Mieloproliferações e Síndromes Mielodisplásicas no Depto. de Leucemias do M.D. Anderson Cancer Center de 2008-2009. Atualmente é médico hematologista do Hospital Israelita Albert Einstein, Serviço de Hematologia. Tem experiência na área de Medicina, com ênfase em Hematologia (Texto informado pelo autor)


Identificação


Nome
Fabio Pires de Souza Santos
Nome em citações bibliográficas
SANTOS, F. P. S.;De Souza Santos, Fabio Pires;Santos, Fábio P. S.;Santos, Fabio P.S.;Santos, F P S;Santos, Fabio P. S.;Santos, Fabio PS;Santos, Favio P;Santos, Fábio Pires S.;de Souza Santos, Fábio Pires;Santos, Fabio Pires de Souza;SANTOS, FÁBIO PIRES DE SOUZA;SANTOS, FABIO P S;P S Santos, Fabio;P. S. SANTOS, FABIO

Endereço


Endereço Profissional
Hospital Israelita Albert Einstein, Serviço de Hematologia, Unidade Perdizes.
Rua Apiacas, 85
Perdizes
05017020 - Sao Paulo, SP - Brasil
Telefone: (11) 21518709


Formação acadêmica/titulação


2005 - 2007
Especialização - Residência médica.
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo. Residência médica em: Hematologia e Hemoterapia
Número do registro: .
Bolsista do(a): Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
2003 - 2005
Especialização - Residência médica.
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo. Residência médica em: Clínica Médica
Número do registro: .
Bolsista do(a): Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
2008 - 2009
Especialização em Leukemia Clinical Fellowship. (Carga Horária: 2000h).
University of Texas M.D. Anderson Cancer Center.
Título: Clinical significance of dose reductions of 2nd-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Orientador: Jorge E. Cortes.
Bolsista do(a): University of Texas M.D. Anderson Cancer Center, UT-MDACC, Estados Unidos.
2007 - 2008
Especialização em Hematologia, Pós Graduação. (Carga Horária: 1920h).
Instituto Israelita de Ensino e Pesquisa Albert Einstein, IIEPAE, Brasil.
Título: Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib.
Orientador: Nelson Hamerschlak.
2007 - 2007
Especialização em Visiting Physician - Leukemia Department. (Carga Horária: 160h).
University of Texas M.D. Anderson Cancer Center.
Título: -.
2003 - 2004
Especialização em Observership - Leukemia Department. (Carga Horária: 320h).
University of Texas M.D. Anderson Cancer Center.
Título: -.
1997 - 2002
Graduação em Medicina.
Universidade de São Paulo, USP, Brasil.




Atuação Profissional



Hospital Israelita Albert Einstein, Serviço de Hematologia, HIAE, Brasil.
Vínculo institucional

2009 - Atual
Vínculo: Médico, Enquadramento Funcional: Médico Hematologista, Carga horária: 32


Bio Sana's Serviços Médicos, BIO SANA'S, Brasil.
Vínculo institucional

2006 - 2007
Vínculo: Medico, Enquadramento Funcional: Médico, Carga horária: 16



Áreas de atuação


1.
Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica/Especialidade: Hematologia.
2.
Grande área: Ciências da Saúde / Área: Medicina / Subárea: Clínica Médica/Especialidade: Sub área de Hematologia: Leucemias, Mieloproliferações e Síndromes Mielodisplásicas.


Idiomas


Inglês
Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.
Português
Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.
Italiano
Compreende Bem, Fala Razoavelmente, Lê Bem, Escreve Pouco.


Prêmios e títulos


2009
European Hematology Association (EHA) Travel Award, European Hematology Association (EHA).
1999
Prêmio Oswaldo Cruz - Melhor Monografia, Departamento Científico da Faculdade de Medicina da Universidade de São Paulo.


Produções



Produção bibliográfica
Artigos completos publicados em periódicos

1.
Santos, Fabio PS2014Santos, Fabio PS; Verstovsek, Srdan . Efficacy of ruxolitinib for myelofibrosis. Expert Opinion on Pharmacotherapy, v. 15, p. 1465-1473, 2014.

2.
Santos, Fabio P. S.2014Santos, Fabio P. S.; TAM, CONSTANTINE S. ; Kantarjian, Hagop ; Cortes, Jorge ; Thomas, Deborah ; POLLOCK, RAPHAEL ; Verstovsek, Srdan . Splenectomy in patients with myeloproliferative neoplasms: efficacy, complications and impact on survival and transformation. Leukemia & Lymphoma (Print), v. 55, p. 121-127, 2014.

3.
Santos, Fabio P.S.2013Santos, Fabio P.S.; Verstovsek, Srdan . What is next beyond janus kinase 2 inhibitors for primary myelofibrosis?. Current Opinion in Hematology, v. 20, p. 123-129, 2013.

4.
CAMPREGHER, PAULO VIDAL2012CAMPREGHER, PAULO VIDAL ; SANTOS, FÁBIO PIRES DE SOUZA ; Perini, Guilherme Fleury ; Hamerschlak, Nelson . Molecular biology of Philadelphia-negative myeloproliferative neoplasms. Revista Brasileira de Hematologia e Hemoterapia (Impresso), v. 34, p. 150-150, 2012.

5.
Santos, Fabio P.S.2012Santos, Fabio P.S.; Verstovsek, Srdan . Therapy with JAK2 Inhibitors for Myeloproliferative Neoplasms. Hematology/Oncology Clinics of North America, v. 26, p. 1083-1099, 2012.

6.
Santos, Fabio P. S.2012Santos, Fabio P. S.; O'Brien, Susan . Small Lymphocytic Lymphoma and Chronic Lymphocytic Leukemia. The Cancer Journal (Sudbury, Mass. Print), v. 18, p. 396-403, 2012.

7.
SANTOS, FABIO P S2012SANTOS, FABIO P S; Cortes, Jorge . Dasatinib for the treatment of Philadelphia chromosome-positive leukemias. Expert Opinion on Pharmacotherapy, v. 13, p. 2381-2395, 2012.

8.
P. S. SANTOS, FABIO2012P. S. SANTOS, FABIO; Verstovsek, Srdan . JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?. Anti-Cancer Agents in Medicinal Chemistry, v. 12, p. 1098-1109, 2012.

9.
Santos, Fabio P. S.2011Santos, Fabio P. S.; Quintás-Cardama, Alfonso . New Drugs for Chronic Myelogenous Leukemia. Current Hematologic Malignancy Reports, v. 6, p. 96-103, 2011.

10.
Santos, Fabio P.S.2011Santos, Fabio P.S.; Kantarjian, Hagop ; McConkey, David ; O'Brien, Susan ; Faderl, Stefan ; Borthakur, Gautam ; Ferrajoli, Alessandra ; Wright, John ; Cortes, Jorge . Pilot Study of Bortezomib for Patients With Imatinib-Refractory Chronic Myeloid Leukemia in Chronic or Accelerated Phase. CL LYMPH MYELOM LEUK, v. 11, p. 355-360, 2011.

11.
Perini, Guilherme F.2011Perini, Guilherme F. ; Kerbauy, Fábio R. ; Fernandes, Juliana Folloni ; Santos, Fábio Pires S. ; Torres, Margareth A. ; Ribeiro, Andreza A. Feitosa ; Hamerschlak, Nelson . Haploidentical non-myeloablative stem cell transplantation as Salvage for graft failure in a patient with juvenile myelomonocytic leukemia. Pediatric Blood & Cancer, v. 57, p. 1084-1084, 2011.

12.
Kerbauy, Fábio R.2011Kerbauy, Fábio R. ; Rodrigues, Morgani ; de Souza Santos, Fábio Pires ; Sobrinho, Jairo Nascimento ; Kutner, José Mauro ; Torres, Margareth A. ; Ribeiro, Andreza Alice Feitosa ; de Lima, Marcos ; Hamerschlak, Nelson . Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning. Leukemia & Lymphoma (Print), v. 52, p. 321-324, 2011.

13.
Santos, Fabio P. S.2011Santos, Fabio P. S.; Kantarjian, Hagop ; Quintás-Cardama, Alfonso ; Cortes, Jorge . Evolution of Therapies for Chronic Myelogenous Leukemia. The Cancer Journal (Sudbury, Mass. Print), v. 17, p. 465-476, 2011.

14.
Santos, Fabio P.S.2011Santos, Fabio P.S.; Verstovsek, Srdan . JAK2 Inhibitors: Are They the Solution?. Clinical Lymphoma, Myeloma & Leukemia, v. 11, p. S28-S36, 2011.

15.
SANTOS, F. P. S.2010 SANTOS, F. P. S.; Kantarjian, H. M. ; Jain, N. ; Manshouri, T. ; Thomas, D. A. ; Garcia-Manero, G. ; Kennedy, D. ; Estrov, Z. ; Cortes, J. ; Verstovsek, S. . Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis. Blood (Philadelphia, PA), v. 115, p. 1131-1136, 2010.

16.
Ravandi, F.2010Ravandi, F. ; Cortes, J. ; Faderl, S. ; O'Brien, S. ; Garcia-Manero, G. ; Verstovsek, S. ; SANTOS, F. P. S. ; Shan, J. ; Brandt, M. ; de Lima, M. ; Pierce, S. ; Kantarjian, H. . Characteristics and outcome of patients with acute myeloid leukemia refractory to one cycle of high dose cytarabine-based induction chemotherapy. Blood (Philadelphia, PA), p. Publicacao, 2010.

17.
Santos, Fabio P. S.2010Santos, Fabio P. S.; Alvarado, Yesid ; Kantarjian, Hagop ; Verma, Dushyant ; O'Brien, Susan ; Mattiuzzi, Gloria ; Ravandi, Farhad ; Borthakur, Gautam ; Cortes, Jorge . Long-term prognostic impact of the use of erythropoietic-stimulating agents in patients with chronic myeloid leukemia in chronic phase treated with imatinib. Cancer (Print), p. n/a-n/a, 2010.

18.
Batty, G. Nicolas2010Batty, G. Nicolas ; Kantarjian, Hagop ; Issa, Jean-Pierre ; Jabbour, Elias ; Santos, Fabio P. S. ; McCue, Deborah ; Garcia-Manero, Guillermo ; Pierce, Sherry ; O'Brien, Susan ; Cortés, Jorge E. ; Ravandi, Farhad . Feasibility of Therapy With Hypomethylating Agents in Patients With Renal Insufficiency. Clinical Lymphoma, Myeloma & Leukemia, v. 10, p. 205-210, 2010.

19.
Santos, Fabio PS2010Santos, Fabio PS; Kantarjian, Hagop ; Garcia-Manero, Guillermo ; Issa, Jean-Pierre ; Ravandi, Farhad . Decitabine in the treatment of myelodysplastic syndromes. Expert Review of Anticancer Therapy, v. 10, p. 9-22, 2010.

20.
Quintás-Cardama, Alfonso2010Quintás-Cardama, Alfonso ; Santos, Fabio P. S. ; Garcia-Manero, Guillermo . Therapy with azanucleosides for myelodysplastic syndromes. NAT REV CLIN ONCOL, v. 7, p. 433-444, 2010.

21.
Kasyan, Armen2010Kasyan, Armen ; Medeiros, L Jeffrey ; Zuo, Zhuang ; Santos, Favio P ; Ravandi-Kashani, Farhad ; Miranda, Roberto ; Vadhan-Raj, Saroj ; Koeppen, Hartmut ; Bueso-Ramos, Carlos E . Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Modern Pathology, v. 23, p. 1113-1126, 2010.

22.
Perini, Guilherme F.2010Perini, Guilherme F. ; Santos, Fabio P. S. ; Ferraz Neto, José Ben-Hur ; Pasqualin, Denise ; Hamerschlak, Nelson . Acute Sickle Hepatic Crisis After Liver Transplantation in a Patient With Sickle ?-Thalassemia. Transplantation, v. 90, p. 463-464, 2010.

23.
Santos, Fabio P. S.2010Santos, Fabio P. S.; Rodrigues, Morgani ; Mac-Donald Bley do Nascimento, Claudia ; Kerbauy, Fábio R. ; Ribeiro, Andreza Alice Feitosa ; Mauro Kutner, José ; Hamerschlak, Nelson . Philadelphia-negative acute lymphoblastic leukemia in a chronic myeloid leukemia patient receiving dasatinib. Cytotherapy (Oxford), v. 12, p. 113-115, 2010.

24.
Santos, Fabio P. S.2010 Santos, Fabio P. S.; Kantarjian, Hagop ; Fava, Carmen ; O Brien, Susan ; Garcia-Manero, Guillermo ; Ravandi, Farhad ; Wierda, William ; Thomas, Deborah ; Shan, Jianquin ; Cortes, Jorge . Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia. British Journal of Haematology (Print), v. 150, p. 303-312, 2010.

25.
Jabbour, E.2010 Jabbour, E. ; Cortes, J. ; SANTOS, F. P. S. ; Jones, D. ; O'Brien, S. ; Rondon, G. ; Popat, U. ; Giralt, S. ; Kebriaei, P. ; Kantarjian, H. ; Champlin, R. ; de Lima, M. . Results of allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia patients who failed tyrosine kinase inhibitors after developing BCR-ABL1 kinase domain mutations. Blood (Philadelphia, PA), p. n/a, 2010.

26.
Santos, Fabio P. S.2010Santos, Fabio P. S.; Kantarjian, Hagop ; Garcia-Manero, Guillermo ; Ravandi, Farhad . The Search for Better Prognostic Models in Myelodysplastic Syndromes. Current Hematologic Malignancy Reports, p. Publicacao, 2010.

27.
Santos, Fabio P. S.2010Santos, Fabio P. S.; Jones, Dan ; Qiao, Wei ; Cortes, Jorge E. ; Ravandi, Farhad ; Estey, Elihu E. ; Verma, Dushyant ; Kantarjian, Hagop ; Borthakur, Gautam . Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia. Cancer (Print), p. n/a-n/a, 2010.

28.
Quintás-Cardama, A2010Quintás-Cardama, A ; Santos, F P S ; Garcia-Manero, G . Histone deacetylase inhibitors for the treatment of myelodysplastic syndrome and acute myeloid leukemia. Leukemia, p. Publicacao, 2010.

29.
Santos, Fabio P.S.2010Santos, Fabio P.S.; Verstovsek, Srdan . JAK2 inhibitors: What's the true therapeutic potential?. Blood Reviews, p. Publicacao, 2010.

30.
Santos, Fabio PS2010Santos, Fabio PS; Bueso-Ramos, Carlos E ; Ravandi, Farhad . Acute erythroleukemia: diagnosis and management. Expert Review of Hematology, v. 3, p. 705-718, 2010.

31.
Santos, F P S2010Santos, F P S; Kantarjian, Hagop ; Cortes, Jorge ; Quintás-Cardama, Alfonso . Bafetinib, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia. Current Opinion in Investigational Drugs (Cessou em 2008. Cont. ISSN 2040-3429 Current Opinion in Investigational Drugs), v. 11, p. 1450-1465, 2010.

32.
Quintás-Cardama, Alfonso2009Quintás-Cardama, Alfonso ; SANTOS, F. P. S. ; Kantarjian, Hagop ; O& ; Faderl, Stefan ; Awais, Ahmed ; Borthakur, Gautam ; Cortes, Jorge . Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure. Cancer (Print), v. 115, p. 3935-3943, 2009.

33.
Perini, Guilherme Fleury2009Perini, Guilherme Fleury ; Santos, Fábio P. S. ; Hamerschlak, Nelson . Alemtuzumab in the reversal of encephalopathy associated with hypereosinophilic syndrome. British Journal of Haematology (Print), p. Pré Publicação, 2009.

34.
Perini, Guilherme F.2009Perini, Guilherme F. ; Santos, Fabio P.S. ; Funke, Vaneuza ; Ruiz, Jefferson ; Neto, Ben-Hur Ferraz ; Hamerschlak, Nelson . Nilotinib post-liver transplantation for acute hepatic failure related to imatinib. Leukemia Research, v. 33, p. e234-e235, 2009.

35.
Santos, F P S2009 Santos, F P S; Faderl, S ; Garcia-Manero, G ; Koller, C ; Beran, M ; O& ; Pierce, S ; Freireich, E J ; Huang, X ; Borthakur, G ; Bueso-Ramos, C ; de Lima, M ; Keating, M ; Cortes, J ; Kantarjian, H ; Ravandi, F . Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution. Leukemia, p. AOP, 2009.

36.
Santos, Fabio P.S.2009Santos, Fabio P.S.; Konoplev, Sergej N. ; Lu, Huifang ; Verstovsek, Srdan . Primary autoimmune myelofibrosis in a 36-year-old patient presenting with isolated extreme anemia. Leukemia Research, p. Pre Published, 2009.

Capítulos de livros publicados
1.
Santos, Fabio P. S.; Verstovsek, Srdan . JAK2 inhibitors for therapy of Myeloproliferative Neoplasms. In: Srdan Verstovsek; Ayalew Tefferi. (Org.). Myeloproliferative Neoplasms Biology and Therapy. New York: Humana Press, 2011, v. , p. 151-168.

2.
Santos, Fábio P. S.; Garcia-Manero, Guillermo . Targeted Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndromes. In: Alfonso Quintas-Cardama; Don L Gibbons; Vince Cataldo. (Org.). Targeted Therapy for Solid Tumors and Hematological Malignancies. New York: Nova Science Publishers, Inc., 2011, v. , p. -.

Resumos publicados em anais de congressos
1.
BAUTZER, V. ; Santos, Fernanda ; Oliveira, Erika ; Macedo, Erika ; Kerbauy, Fábio R. ; Kutner, José Mauro ; Fernandes, Juliana Folloni ; Ribeiro, Andreza Alice Feitosa ; CAMPREGHER, PAULO VIDAL ; Rodrigues, Morgani ; Sobrinho, Jairo Nascimento ; Odone, Vicente ; Bollmann, Patricia ; Hamerschlak, Nelson ; Santos, Fabio Pires de Souza . Development of BK Virus-Associated Hemorrhagic Cystitis (HC) Is Associated with Decreased Survival Post-Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT). In: American Society of Hematology Annual Meeting, 2012, Atlanta. American Society of Hematology Annual Meeting, 2012. v. 120. p. Abstract 1933.

2.
Almeida, Alessandro ; Macedo, Erika ; Mac-Donald Bley do Nascimento, Claudia ; Kerbauy, Fábio R. ; CAMPREGHER, PAULO VIDAL ; Odone, Vicente ; LIMA, M. ; Sobrinho, Jairo Nascimento ; Fernandes, Juliana Folloni ; Rodrigues, M ; Hamerschlak, Nelson ; Santos, Fábio P. S. . Cytomegalovirus infection and lymphopenia are associated with increased mortality post Autologous Stem Cell Transplantation. In: Annual Meeting of The American Society of Hematology, 2012, Atlanta. Annual Meeting of The American Society of Hematology Abstracts, 2012. v. 120. p. Abstract 4208.

3.
Santos, Fábio P. S.; Tam, CS ; Kantarjian, H ; Cortes, Jorge E. ; Thomas, D. A. ; POLLOCK, R. ; Verstovsek, Srdan . Splenectomy in Patients with Myeloproliferative Neoplasms (MPNs): Efficacy, Complications and Impact on Survival and Transformation. In: Annual Meeting of The American Society of Hematology, 2012, Atlanta. Abstracts of the Annual Meeting of the American Society of Hematology, 2012. v. 120. p. Abstract 2853.

4.
Santos, Fabio P.S.; Nascimento, CMDB ; Helman, Ricardo ; Perini, Guilherme Fleury ; Silva, Leandro de Padua ; Bello, Isabel ; KASSAB, C. ; Esposito, Brenno Pania ; Ribeiro, Murilo Sergio S ; Nomura, Cesar ; Kay, Fernando Uliana ; Baroni, Ronaldo ; Velloso, Elvira ; Hamerschlak, Nelson . Magnetic Resonance Imaging of Iron Overload in Patients with Myelodysplastic Syndromes. In: Annual Meeting of the American Society of Hematology, 2011, San Diego. Abstracts of the Annual Meeting of The American Society of Hematology, 2011. v. 118. p. Abstract 3827.

5.
Santos, F P S; Kantarjian, H ; Jain, N. ; Thomas, D ; Garcia-Manero, G ; Cortes, J ; Verstovsek, Srdan . Phase II Study of CEP-701, an orally available JAK2 inhibitor, in patients with primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis. In: Annual Meeting of The European Hematology Association, 2009, Berlin. Haematologica, Abstract Book of the 14th Congress of the European Hematology Association, Berlin, Germany, June 4 7, 2009, 2009. v. 94. p. 1-694.

6.
Santos, F P S; Qiao, W ; Cortes, J ; jones, d ; Ravandi, F ; verma, d ; Kantarjian, H ; Borthakur, G . Prognostic role of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia. In: Annual Meeting of The American Society of Clinical Oncology, 2009, Orlando. Journal of Clinical Oncology, 2009 ASCO Annual Meeting Proceedings (Post-Meeting Edition), 2009. v. 27. p. 7015.

7.
Santos, F P S; Faderl, S ; Garcia-Manero, G ; Koller, C ; Beran, M ; Borthakur, G ; Bueso-Ramos, C ; Keating, M ; Cortes, J ; Kantarjian, H ; Ravandi, F . Acute Erythroleukemia: An Analysis of 108 Patients Treated with Cytarabine-Containing Regimens at the M.D. Anderson Cancer Center.. In: Annual Meeting of the American Society of Hematology, 2008, San Francisco. Blood (ASH Annual Meeting Abstracts), 2008. v. 112. p. 925.

8.
Santos, F P S; Kantarjian, H ; Fava, C ; O´Brien, S ; Garcia-Manero, G ; Kornblau, S ; Ravandi, F ; Wierda, W ; Cortes, J . Clinical Significance of Dose Reductions of Second-Generation Tyrosine Kinase Inhibitors (TKI) in Patients (Pts) with Chronic Myeloid Leukemia (CML). In: Annual Meeting of the American Society of Hematology, 2008, San Francisco. Blood (ASH Annual Meeting Abstracts), 2008. v. 112. p. 3217.

9.
Santos, F P S; Nascimento, CMDB ; Feitosa, AA ; Rodrigues, M ; Silva, F ; Kutner, JM ; Hamerschlak, Nelson . Case Report: Second Unrelated Allogeneic Stem Cell Transplantation for Relapsed Acute Lymphoblastic Leukemia.. In: XI Congresso Anual da Sociedade Brasileira de Transplante de Medula Óssea, 2007, Gramado. Revista Brasileira de Hematologia e Hemoterapia, 2007. v. 29. p. -.

10.
Nascimento, CMDB ; Santos, F P S ; Feitosa, AA ; Rodrigues, M ; Toledo, C ; Kutner, JM ; Hamerschlak, Nelson . Case Report: Third Autologous Stem Cell Transplantation for Relapsed Multiple Myeloma. In: XI Encontro Anual da Sociedade Brasileira de Transplante de Medula Óssea, 2007, Gramado. Revista Brasileira de Hematologia e Hemoterapia, 2007. v. 29.

11.
Rodrigues, M ; Feitosa, AA ; Kutner, JM ; SANTOS, F. P. S. ; Nascimento, CMDB ; Odoni, V ; Troster, E ; Brand, JL ; Mota, M ; Hamerschlak, Nelson . Autoimmune manifestations after umbilical cord blood cell transplantation. In: XXX Congresso Brasileiro de Hematologia e Hemoterapia, 2007, São Paulo. Revista Brasileira de Hematologia e Hemoterapia, 2007.

12.
Nascimento, CMDB ; Santos, F P S ; Rodrigues, M ; Feitosa, AA ; Kutner, JM ; D'Amico, E ; Colombini, M ; Hamerschlak, Nelson . Case Report: Severe Factor X Deficiency and Pregnancy. In: XXX Encontro Brasileiro de Hematologia e Hemoterapia, 2007, São Paulo. Revista Brasileira de Hematologia e Hemoterapia, 2007. v. 29.

13.
Nascimento, CMDB ; Santos, F P S ; Rodrigues, M ; Feitosa, AA ; Kutner, JM ; D'Amico, E ; Colombini, M ; Hidalgo, R ; Lima, IK ; Neto, Ben-Hur Ferraz ; Hamerschlak, Nelson . Budd-Chiari Syndrome with Hyperhomocysteinemia and MTHFR C677T Mutation. In: XXX Congresso Brasileiro de Hematologia e Hemoterapia, 2007, São Paulo. Revista Brasileira de Hematologia e Hemoterapia, 2007. v. 29.

14.
Santos, F P S; Nascimento, CMDB ; Rodrigues, M ; Feitosa, AA ; Kutner, JM ; Hidalgo, R ; Neto, Ben-Hur Ferraz ; Hamerschlak, Nelson . Aplastic Anemia After Liver Transplantation for Fulminant Hepatitis. In: XXX Congresso Brasileiro de Hematologia e Hemoterapia, 2007, São Paulo. Revista Brasileira de Hematologia e Hemoterapia, 2007. v. 29.

15.
Santos, F P S; Nascimento, CMDB ; Rodrigues, M ; Feitosa, AA ; Kutner, JM ; Hidalgo, R ; Moraes-Junior, JM ; Neto, Ben-Hur Ferraz ; Hamerschlak, Nelson . Intra-Hepatic Sickling Crisis after Liver Transplantation in a patient with SBeta-thalassemia. In: XXX Congresso Brasileiro de Hematologia e Hemoterapia, 2007, São Paulo. Revista Brasileira de Hematologia e Hemoterapia, 2007. v. 29.

Artigos aceitos para publicação
1.
Santos, F P S; Ravandi, F . Advances in treatment of Chronic Myelogenous Leukemia - New treatment options with tyrosine kinase inhibitors. Leukemia and Lymphoma, 2009.

Apresentações de Trabalho
1.
Santos, F P S; Kantarjian, Hagop ; Jain, N. ; Thomas, D ; Garcia-Manero, G ; Cortes, J ; Verstovsek, Srdan . Phase II Study of CEP-701, an orally available JAK2 inhibitor, in patients with primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis. 2009. (Apresentação de Trabalho/Comunicação).

2.
Santos, Fábio P. S.; Kantarjian, Hagop ; Kadia, Tapan ; BIVINS, C. ; O'Brien, Susan ; Ravandi-Kashani, Farhad ; Cortes, Jorge ; Faderl, Stefan ; Pierce, Sherry ; Jabbour, Elias . High Prevalence of FLT3 - ITD Mutations in Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Central Nervous System (CNS) Relapse. 2009. (Apresentação de Trabalho/Comunicação).



Eventos



Participação em eventos, congressos, exposições e feiras
1.
11th International Symposium on Myelodysplastic Syndromes. 2011. (Simpósio).

2.
15o. Congresso Anual da Sociedade Brasileira de Transplante de Medula Óssea. 2011. (Congresso).

3.
36th Annual Meeting of the European Group for Blood and Marrow Transplantation. 2010. (Congresso).

4.
52nd Annual Meeting of the American Society of Hematology. 2010. (Congresso).

5.
13o. Congresso da Sociedade Brasileira de Transplante de Medula Óssea. 2009. (Congresso).

6.
14th Annual Meeting of the European Hematology Association. Phase II Study of CEP-701, an orally available JAK2 inhibitor, in patients with primary myelofibrosis and post-polycythemia vera/essential thrombocythemia myelofibrosis. 2009. (Congresso).

7.
50th Annual Meeting of the American Society of Clinical Oncology. 2009. (Congresso).

8.
51st Annual Meeting of the American Society of Hematology. High Prevalence of FLT3 - ITD Mutations in Patients (pts) with Acute Myeloid Leukemia (AML) Who Present with Central Nervous System (CNS) Relapse. 2009. (Congresso).

9.
50h Annual Meeting of the American Society of Hematology. 2008. (Congresso).

10.
30o. Congresso Brasileiro de Hematologia e Hemoterapia. 2007. (Congresso).

11.
49th Annual Meeting of the American Society of Hematology. 2007. (Congresso).

12.
29o. Congresso Brasileiro de Hematologia e Hemoterapia. 2006. (Congresso).

13.
28o. Congresso Brasileiro de Hematologia e Hemoterapia. 2005. (Congresso).




Página gerada pelo Sistema Currículo Lattes em 18/02/2019 às 19:42:40